June 9-16, 2016
Last Updated: Jun 10, 2016
- BRAF V600E mutation in metastatic colorectal cancer: methods of detection and correlation with clinical and pathologic features.
Roma Cristin, et al. Cancer biology & therapy 2016 6 0 - Copy number analysis of whole-genome data using BIC-seq2 and its application to detection of cancer susceptibility variants.
Xi Ruibin, et al. Nucleic acids research 2016 6 - Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers.
D'Haene Nicky et al. PloS one 2015 10(9) e0138245 - Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.
Møller Pål et al. Gut 2016 Jun - Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.
Lowery Jan T et al. Cancer 2016 Jun - CDH1 rs9929218 variant at 16q22.1 contributes to colorectal cancer susceptibility.
Han Peng, et al. Oncotarget 2016 6 - Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity.
Hu Lei, et al. International journal of environmental research and public health 2016 0 (6) - Novel Mutations in MLH1 and MSH2 Genes in Mexican Patients with Lynch Syndrome.
Moreno-Ortiz Jose Miguel, et al. Gastroenterology research and practice 2016 0 5278024 - Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.
Song Mingyang, et al. Cancer prevention research (Philadelphia, Pa.) 2016 5 - Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.
Kothari Nishi, et al. Cancer 2016 5 - The Effect of the CYP1A1*2A Allele on Colorectal Cancer Susceptibility in a British Population.
Özta? Ezgi, et al. Genetic testing and molecular biomarkers 2016 5 - Prevalence of Germline Mutations in the Spindle Assembly Checkpoint Gene BUB1B in Individuals with Early-Onset Colorectal Cancer.
Hahn Marc-Manuel, et al. Genes, chromosomes & cancer 2016 5 - Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).
Xicola Rosa M, et al. Carcinogenesis 2016 5 - A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study).
Yoshida Motoki, et al. Oncology 2016 5 - Allele-specific expression of mutated in colorectal cancer (MCC) gene and alternative susceptibility to colorectal cancer in schizophrenia.
Wang Yang, et al. Scientific reports 2016 0 26688 - AXIN2 Polymorphisms and Its Association with Colorectal Cancer in Mexican Patients.
Rosales-Reynoso Mónica Alejandra, et al. Genetic testing and molecular biomarkers 2016 5 - Matrix Metalloproteinase (MMP) -2, -7 and-9 Promoter Polymorphisms in Colorectal Cancer in ethnic Kashmiri population- a case control study and a mini review.
Banday Mujeeb Zafar, et al. Gene 2016 5 - UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer.
Xu Chunlei, et al. Cancer chemotherapy and pharmacology 2016 5 - Passive Smoking and Risk of Colorectal Cancer: A Meta-analysis of Observational Studies.
Yang Chen, et al. Asia-Pacific journal of public health / Asia-Pacific Academic Consortium for Public Health 2016 5 - Genome-wide association study of colorectal cancer in Hispanics.
Schmit Stephanie L, et al. Carcinogenesis 2016 6 (6) 547-56 - Adenomas as a risk factor in familial colorectal cancer: implications for screening and surveillance in the UK.
Buczacki Sja et al. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2016 May - Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation.
Nicholls Stuart G et al. BMC medical genomics 2016 9(1) 25 - Fertility after young-onset colorectal cancer: a study of subjects with Lynch syndrome.
Stupart D et al. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 2015 Sep 17(9) 787-93 - Clinical impact and network of determinants of tumour necrosis in colorectal cancer.
Väyrynen Sara A, et al. British journal of cancer 2016 5 - Clinical significance of <i>TLR1</i> I602S polymorphism for patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab.
Okazaki Satoshi, et al. Molecular cancer therapeutics 2016 5 - Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
Masugi Yohei, et al. Gut 2016 5 - In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth.
Bordonaro Michael, et al. Cancers 2016 0 (5) - Fc-? Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer.
Liu Geoffrey, et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 5 (10) 2435-44 - Feasibility of novel PPP1R15A and proposed ANXA11 single nucleotide polymorphisms as predictive markers for bevacizumab regimen in metastatic colorectal cancer.
Roh Seon Ae, et al. Journal of cancer research and clinical oncology 2016 5 - Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.
Kallenberg F G J et al. Alimentary pharmacology & therapeutics 2016 May
- Human (0)
- Pathogen (5)
- Human (3962)
- Pathogen (0)
- Human (214)
- Pathogen (0)
.png)
No hay comentarios:
Publicar un comentario